BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Almalki AH, Sadagah LF, Qureshi M, Maghrabi H, Algain A, Alsaeed A. Atypical hemolytic-uremic syndrome due to complement factor I mutation. World J Nephrol 2017; 6(6): 243-250 [PMID: 29226095 DOI: 10.5527/wjn.v6.i6.243]
URL: https://www.wjgnet.com/2307-8960/full/v6/i6/243.htm
Number Citing Articles
Yulia V. Lavrishcheva, Alexander A. Yakovenko, Dmitrii A. Kudlai. The experience of using the Russian biosimilar of the original drug eculizumab for the treatment of patients with atypical hemolytic-uremic syndromeTerapevticheskii arkhiv 2020; 92(6): 76 doi: 10.26442/00403660.2020.06.000649